Health and Fitness Health and Fitness
Wed, November 3, 2010
[ Wed, Nov 03rd 2010 ] - Market Wire
Emergent BioSolutions Receives Loan Repayment from Protein Sciences Corporation
[ Wed, Nov 03rd 2010 ] - Market Wire
Illumina Introduces TruSeqa" Sample Prep and Exome Enrichment Kits
[ Wed, Nov 03rd 2010 ] - Market Wire
CardioNet, Inc. Announces National Reimbursement Rate for Mobile Cardiovascular Telemetry
[ Wed, Nov 03rd 2010 ] - Market Wire
Curis Awarded $500,000 in Grants Under the Patient Protection and Affordable Care Act
[ Wed, Nov 03rd 2010 ] - Market Wire
Cardiovascular Systems Settles Employment Litigation
[ Wed, Nov 03rd 2010 ] - Market Wire
BioCryst Awarded $1.1 Million in Grants for Qualifying Therapeutic Development Projects
[ Wed, Nov 03rd 2010 ] - Market Wire
Orthovita Reports 2010 Third Quarter Financial Results And Updates Full Year Financial Guidance
[ Wed, Nov 03rd 2010 ] - Market Wire
TSO3 ANNOUNCES FINANCIAL RESULTS FOR Q3 2010
Tue, November 2, 2010
[ Tue, Nov 02nd 2010 ] - Market Wire
Unigene Names Alex Martin VP Business Development and Head of Commercial Operations
[ Tue, Nov 02nd 2010 ] - Market Wire
Geron Awarded Grants Under Qualifying Therapeutic Discovery Project Program
[ Tue, Nov 02nd 2010 ] - Market Wire
Incyte Achieves $50 Million in Milestones for Ini .. se III Clinical Trial of Novel JAK1 and JAK2 Inhi
[ Tue, Nov 02nd 2010 ] - Market Wire
Ligand Announces Approval for Revolade® in Japan
[ Tue, Nov 02nd 2010 ] - Market Wire
AtriCure Reports Third Quarter 2010 Financial Results
[ Tue, Nov 02nd 2010 ] - Market Wire
CytRx Awarded $735,000 Grant under the Qualifying Therapeutic Discovery Project Program
[ Tue, Nov 02nd 2010 ] - Market Wire
ACADIA Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 9, 2010
[ Tue, Nov 02nd 2010 ] - Market Wire
SAUDI ARABIA';S NATIONAL GUARD HEALTH AFFAIRS SIG .. S AND IMRIS FOR FUTURE TECHNOLOGY FOR USE IN RADI
[ Tue, Nov 02nd 2010 ] - Market Wire
ZIOPHARM Oncology Awarded $733,000 Grant under th .. . Qualified Therapeutic Discovery Project Program
[ Tue, Nov 02nd 2010 ] - Market Wire
Enzon Reports Third Quarter 2010 Results
[ Tue, Nov 02nd 2010 ] - Market Wire
ArthroCare Receives FDA Clearance for SpeedFix
[ Tue, Nov 02nd 2010 ] - Market Wire
Cascade Technologies Corp. Enters Into Letter of Intent to Acquire Assets of AcuNetx, Inc.
[ Tue, Nov 02nd 2010 ] - Market Wire
BioScrip Names Richard M. Smith as Chief Executive Officer
[ Tue, Nov 02nd 2010 ] - Market Wire
MEDNAX Earns $1.06 Non-GAAP for 2010 Third Quarter
[ Tue, Nov 02nd 2010 ] - Market Wire
ImmunoGen, Inc. Announces Presentations at the 22 .. sium on Molecular Targets and Cancer Therapeutics
[ Tue, Nov 02nd 2010 ] - Market Wire
Pro-Pharmaceuticals to Receive $489,000 in Federa .. tin-Targeting Cancer and Liver Fibrosis Compounds
[ Tue, Nov 02nd 2010 ] - Market Wire
RXi Pharmaceuticals Awarded $1 Million in IRS Grants to Advance RNAi Therapeutics
[ Tue, Nov 02nd 2010 ] - Market Wire
GTx, Inc. Announces Third Quarter 2010 Financial Results Conference Call and Webcast
[ Tue, Nov 02nd 2010 ] - Market Wire
Inhibitex Announces Data Presentations at the 61s .. can Association for the Study of Liver Diseases (
[ Tue, Nov 02nd 2010 ] - Market Wire
Ligand Awarded $2 Million from U.S. Government Un .. er the Patient Protection and Affordable Care Act
[ Tue, Nov 02nd 2010 ] - Market Wire
Celldex Reports Third Quarter 2010 Financial Results
[ Tue, Nov 02nd 2010 ] - Market Wire
Corgenix to Host Conference Call to Discuss First Quarter Results

Corgenix to Host Conference Call to Discuss First Quarter Results


Published on 2010-11-02 16:13:26 - Market Wire
  Print publication without navigation


DENVER--([ BUSINESS WIRE ])--Corgenix Medical Corporation (OTC BB: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, November 11, 2010, at 4:00 p.m. EST to discuss the Companya™s financial and operating performance for its quarter ended September 30, 2010, and the status of the Companya™s product development and marketing activities.

Corgenix invites all those interested in hearing managementa™s discussion of the quarter results to join the call by dialing:

U.S. attendees: (800) 895-0198
International attendees: +1 785 424 1053
Conference code is: CORGENIX

A question-and-answer session will follow the presentation by Corgenix management.

A replay will be available for 30 days following the call by dialing (800) 695-0974 for U.S. participants and +1 402 220 1459 for international participants.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the worlda™s only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA process. More information is available at [ www.corgenix.com ].

Contributing Sources